
Charles Ornstein
Charles Ornstein is managing editor, local, overseeing ProPublica’s local initiatives. These include offices in the Midwest, South, Southwest and Northwest, a joint initiative with the Texas Tribune, and the Local Reporting Network, which works with local news organizations to produce accountability journalism on issues of importance to their communities.
Need to Get in Touch?
Charles Ornstein is managing editor, local, overseeing ProPublica’s local initiatives. These include offices in the Midwest, South, Southwest and Northwest, a joint initiative with the Texas Tribune, and the Local Reporting Network, which works with local news organizations to produce accountability journalism on issues of importance to their communities. From 2008 to 2017, he was a senior reporter covering health care and the pharmaceutical industry. He then worked as a senior editor and deputy managing editor.
Prior to joining ProPublica, he was a member of the metro investigative projects team at the Los Angeles Times. In 2004, he and Tracy Weber were lead authors on a series on Martin Luther King Jr./Drew Medical Center, a troubled hospital in South Los Angeles. The articles won the 2005 Pulitzer Prize for public service, the Robert F. Kennedy Journalism Award, and the Sigma Delta Chi Award for Public Service.
In 2009, he and Weber worked on a series of stories that detailed serious failures in oversight by the California Board of Registered Nursing and nursing boards around the country. The work was a finalist for the 2010 Pulitzer Prize for public service.
Projects edited or co-edited by Ornstein have won the Pulitzer Prize for public service, the Selden Ring Award for Investigative Reporting, the Scripps Howard Impact Award, the IRE Award, the Online Journalism Award and other major journalism honors.
He previously worked at the Dallas Morning News, where he covered health care on the business desk and worked in the Washington bureau. Ornstein is a past president of the Association of Health Care Journalists and an adjunct journalism professor at Columbia University. Ornstein is a graduate of the University of Pennsylvania.
Generic Drug Prices Are Declining, But Many Consumers Aren’t Benefiting
Outcry has been building over the rising cost of brand-name medications, but the price of generic drugs has been moving in the opposite direction. The stock prices of generic manufacturers have tumbled, but many consumers aren’t paying less at the pharmacy counter.
by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,
Take the Generic Drug, Patients Are Told — Unless Insurers Say No
Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more.
by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,
Accreditors Can Keep Their Hospital Inspection Reports Secret, Feds Decide
Reversing course, federal health officials withdrew a proposal that would have required private accrediting organizations to publicly release reports of problems they found in health care facilities. Accreditors and hospitals had panned the idea; consumer advocates and business groups supported it.
by Charles Ornstein,
McCain’s Brain Cancer Draws Renewed Attention to Possible Agent Orange Connection
For years, Vietnam vets and their widows have been pushing the VA to extend benefits to those exposed to the toxic herbicide and later stricken with glioblastoma. The VA has said no, but advocates hope the agency will now revisit the issue.
by Charles Ornstein, ProPublica, and Mike Hixenbaugh, Houston Chronicle,
‘Extreme’ Use of Painkillers and Doctor Shopping Plague Medicare, New Report Says
Some Medicare beneficiaries are being prescribed opioids by 10 or more doctors, or are filling prescriptions for more than 1,000 pills a month. Hundreds of doctors appear to be prescribing indiscriminately, says the inspector general of Health and Human Services.
by Charles Ornstein,
Drugmakers’ Money-Back Guarantees: an Answer to Rising Prices or a ‘Carnival Game’
Pharmaceutical companies are increasingly agreeing to refund money if patients don't respond to medications as expected. The Trump administration is intrigued, but critics say the deals are unlikely to reduce consumers’ bills.
by Charles Ornstein, ProPublica, and Katie Thomas, The New York Times,
The Medicaid Threat That Isn’t Getting Much Attention
As Republicans in Congress work to roll back the Affordable Care Act, they and some states are proposing major changes to the Medicaid program. Researchers say these changes would cost millions their health coverage.
by Charles Ornstein,
Medicare Halts Release of Much-Anticipated Data
The government had planned to share data with researchers on patients enrolled in Medicare Advantage health plans. Then, suddenly, it didn’t.
by Charles Ornstein,
Nursing Home Workers Still Posting Nude and Vulgar Photos of Residents on Snapchat
Federal and state officials have increased their focus on the problem, but ProPublica found 18 incidents in the last year in which employees at nursing homes and assisted living facilities posted unauthorized photos and videos of residents on social media platforms.
by Charles Ornstein,
Inappropriate Social Media Posts by Nursing Home Workers, Detailed
Below are details of 65 incidents since 2012 in which workers at nursing homes and assisted-living centers shared photos or videos of residents on social media networks. The details come from government inspection reports, court cases and media reports.
by Charles Ornstein and Jessica Huseman,